ImportRefusal LogoImportRefusal

RABISAN INDIA ELECTRO HOMEO PHAR

⚠️ Moderate Risk

FEI: 3026090776 • Himachal Pradesh • INDIA

FEI

FEI Number

3026090776

📍

Location

Himachal Pradesh

🇮🇳

Country

INDIA
🏢

Address

Trimurti Complex Mohall, , Himachal Pradesh, , India

Moderate Risk

FDA Import Risk Assessment

44.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
3
Unique Violations
3/9/2023
Latest Refusal
3/9/2023
Earliest Refusal

Score Breakdown

Violation Severity
63.3×40%
Refusal Volume
28.8×30%
Recency
28.6×20%
Frequency
50.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1185×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32805×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

755×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
3/9/2023
61KDL06BELLADONNA (EXT) (ANTI-CHOLINERGIC)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/9/2023
62CDB99ANTI-HYPERTENSIVE N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/9/2023
62CDB99ANTI-HYPERTENSIVE N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/9/2023
60SDL99ANTACID, N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/9/2023
60SDL99ANTACID, N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is RABISAN INDIA ELECTRO HOMEO PHAR's FDA import refusal history?

RABISAN INDIA ELECTRO HOMEO PHAR (FEI: 3026090776) has 5 FDA import refusal record(s) in our database, spanning from 3/9/2023 to 3/9/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. RABISAN INDIA ELECTRO HOMEO PHAR's FEI number is 3026090776.

What types of violations has RABISAN INDIA ELECTRO HOMEO PHAR received?

RABISAN INDIA ELECTRO HOMEO PHAR has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about RABISAN INDIA ELECTRO HOMEO PHAR come from?

All FDA import refusal data for RABISAN INDIA ELECTRO HOMEO PHAR is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.